Bone densitometers sales will grow through 2036, led by DXA at a 63.0% share of the technology segment in 2026. The market is expected to reach USD 391.3 million in 2026 and USD 584.8 million by 2036, creating an absolute opportunity of USD 193.1 million between 2026 and 2036.